Join me @ IBOtoolbox for free.
Chuck Reynolds
Member Since: 12/6/2012
  
performance / stats
Country: United States
Likes Received: 1689
Featured Member: 0 times
Associates: 2326
Wall Posts: 2021
Comments Made: 1494
Press Releases: 1993
Videos: 1
Phone: 559-369-7791
Skype:     chuck212
profile visitor stats
TODAY: 15
THIS MONTH: 2711
TOTAL: 391567
are we ibo associates?
recent videos
active associates
Whitney Jacqueline     
Last logged on: 7/19/2019


Csaba Juhasz    
Last logged on: 7/19/2019


Tony Wahlund    
Last logged on: 7/19/2019


Mike Davey     
Last logged on: 7/19/2019


Mike Savage Jr    
Last logged on: 7/19/2019


Christopher Wright    
Last logged on: 7/19/2019


IBOtoolbox Admin     
Last logged on: 7/19/2019


James Doan       
Last logged on: 7/19/2019


Sule Yesufu    
Last logged on: 7/19/2019


Jerold Rivera    
Last logged on: 7/19/2019


Brandon J Urquhart I    
Last logged on: 7/19/2019


Eugeniusz Nowak    
Last logged on: 7/19/2019


Arnold Fisher    
Last logged on: 7/19/2019


Mike Seals    
Last logged on: 7/19/2019


Eugenijus Sakalauskas    
Last logged on: 7/19/2019


other ibo platforms











Chuck Reynolds   My Press Releases

Resveratrol and diabetic nephropathy

Published on 3/22/2019
For additional information  Click Here

Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.

                                            

Diabetic nephropathy is a serious microvascular complication

and one of the main causes of end-stage renal disease. Various studies have revealed that increased oxidative stress is a major pathophysiological mechanism which is involved in the etiology of diabetic nephropathy. Resveratrol, a polyphenolic phytoalexin present in red wine, is known to possess potent antioxidant properties and thus we aimed to examine its effect on renal function and oxidative stress in streptozotocin (STZ)-induced diabetic rats. Diabetes was induced by a single intraperitoneal injection of STZ (65 mg/kg) in rats. After 4 weeks of STZ injection, rats were divided into four groups: the control rats, diabetic rats and diabetic rats treated with resveratrol (5 and 10 mg/kg, orally) respectively from week 4 up till week 6. At the termination of the experiments, urine albumin excretion, urine output, serum creatinine, blood urea nitrogen, creatinine and urea clearance were measured. The levels of the renal oxidative stress markers malonaldehyde and glutathione and the antioxidant enzymes superoxide dismutase and catalase were measured in kidney homogenate. STZ-injected rats showed significant increases in blood glucose, polyuria, proteinuria and a decrease in body weight compared with age-matched control rats. After 6 weeks, diabetic rats exhibited renal dysfunction, as evidenced by reduced creatinine and urea clearance, and proteinuria along with a marked increase in oxidative stress, as determined by lipid peroxidation and activities of key antioxidant enzymes. Treatment with resveratrol significantly attenuated renal dysfunction and oxidative stress in diabetic rats. The present study reinforces the important role of oxidative stress in diabetic kidney and points towards the possible antioxidative mechanism being responsible for the renoprotective action of resveratrol.

Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.

BACKGROUND:

Diabetic nephropathy (DN) has been recognized as the leading cause of end-stage renal disease. Resveratrol (RSV), a polyphenolic compound, has been indicated to possess an insulin-like property in diabetes. In the present study, we aimed to investigate the renoprotective effects of RSV and delineate its underlying mechanism in early-stage DN.

METHODS:

The protective effects of RSV on DN were evaluated in streptozotocin (STZ)-induced diabetic rats.

RESULTS:

The plasma glucose, creatinine, and blood urea nitrogen were significantly elevated in STZ-induced diabetic rats. RSV treatment markedly ameliorated hyperglycemia and renal dysfunction in STZ-induced diabetic rats. The diabetes-induced superoxide anion and protein carbonyl levels were also significantly attenuated in RSV-treated diabetic kidney. The AMPK protein phosphorylation and expression levels were remarkably reduced in diabetic renal tissues. In contrast, RSV treatment significantly rescued the AMPK protein expression and phosphorylation compared to non-treated diabetic group. Additionally, hyperglycemia markedly enhanced renal production of proinflammatory cytokine IL-1β. RSV reduced IL-1β but increased TNF-α and IL-6 levels in the diabetic kidneys.

CONCLUSIONS:

Our findings suggest that RSV protects against oxidative stress, exhibits concurrent proinflammation and anti-inflammation, and up-regulates AMPK expression and activation, which may contribute to its beneficial effects on the early stage of

Article Produced By
Department and Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University

https://www.ncbi.nlm.nih.gov/pubmed/21699681

Member Note: To comment on this PR, simply click reply on the owners main post below.
-  Copyright 2016 IBOsocial  -            Part of the IBOtoolbox family of sites.